• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转基因小鼠展示了尿激酶受体基因组织特异性表达的新启动子区域。

Transgenic mice demonstrate novel promoter regions for tissue-specific expression of the urokinase receptor gene.

作者信息

Wang Heng, Hicks John, Khanbolooki Parham, Kim Sun-Jin, Yan Chunhong, Wang Yao, Boyd Douglas

机构信息

Department of Cancer Biology, MD Anderson Cancer Center, Houston, Texas 77030, USA.

出版信息

Am J Pathol. 2003 Aug;163(2):453-64. doi: 10.1016/S0002-9440(10)63675-9.

DOI:10.1016/S0002-9440(10)63675-9
PMID:12875967
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1868205/
Abstract

The urokinase-type plasminogen activator receptor (u-PAR) contributes to cell migration and proteolysis in normal and cancerous tissues. Currently, there are no reports on the regulatory regions directing tissue-specific expression. Consequently, we undertook a study to identify novel promoter regions required for expression of this gene in transgenic mice bearing a LacZ reporter regulated by varying amounts (0.4, 1.5, and 8.5 kb) of upstream sequence. The 0.4-kb u-PAR upstream sequence directed weak and strong LacZ expression in the placenta and epididymis, respectively, both of which are tissues that express endogenous u-PAR. Conversely, transgene expression in the apical cells of the colon positive for endogenous u-PAR protein required 1.5 kb of upstream sequence for optimal expression. Furthermore, chromatin accessibility assays coupled with real-time polymerase chain reaction suggested a putative regulatory region spanning -1295/-1192 driving u-PAR expression in colonic cells. Interestingly, placental transgene expression was augmented with the 8.5-kb upstream fragment compared with the shorter 1.5-kb fragment indicating contributing element(s) between -1.5 and -8.5 kb. Thus, while 0.4 kb of upstream sequence directs u-PAR expression in the epididymis, sequences located between -0.4 and -1.5 kb and between -1.5 and -8.5 kb are required for optimal tissue-specific expression in the colon and the placenta, respectively.

摘要

尿激酶型纤溶酶原激活物受体(u-PAR)在正常组织和癌组织中有助于细胞迁移和蛋白水解。目前,尚无关于指导组织特异性表达的调控区域的报道。因此,我们进行了一项研究,以确定在携带由不同长度(0.4、1.5和8.5 kb)上游序列调控的LacZ报告基因的转基因小鼠中,该基因表达所需的新启动子区域。0.4 kb的u-PAR上游序列分别在胎盘和附睾中指导LacZ的弱表达和强表达,这两个组织均表达内源性u-PAR。相反,在内源性u-PAR蛋白呈阳性的结肠顶端细胞中,转基因表达需要1.5 kb的上游序列才能实现最佳表达。此外,染色质可及性分析与实时聚合酶链反应表明,存在一个推定的调控区域,跨度为-1295/-1192,驱动结肠细胞中u-PAR的表达。有趣的是,与较短的1.5 kb片段相比,8.5 kb的上游片段增强了胎盘转基因的表达,表明在-1.5至-8.5 kb之间存在起作用的元件。因此,虽然0.4 kb的上游序列指导附睾中u-PAR的表达,但分别需要-0.4至-1.5 kb之间以及-1.5至-8.5 kb之间的序列才能在结肠和胎盘中实现最佳的组织特异性表达。

相似文献

1
Transgenic mice demonstrate novel promoter regions for tissue-specific expression of the urokinase receptor gene.转基因小鼠展示了尿激酶受体基因组织特异性表达的新启动子区域。
Am J Pathol. 2003 Aug;163(2):453-64. doi: 10.1016/S0002-9440(10)63675-9.
2
The Kruppel-like KLF4 transcription factor, a novel regulator of urokinase receptor expression, drives synthesis of this binding site in colonic crypt luminal surface epithelial cells.Kruppel样转录因子KLF4是尿激酶受体表达的新型调节因子,可驱动结肠隐窝腔面上皮细胞中该结合位点的合成。
J Biol Chem. 2004 May 21;279(21):22674-83. doi: 10.1074/jbc.M401257200. Epub 2004 Mar 18.
3
Induction of urokinase-type plasminogen activator receptor by IL-1 beta.白细胞介素-1β诱导尿激酶型纤溶酶原激活物受体的生成。
Am J Respir Cell Mol Biol. 1997 Jun;16(6):683-92. doi: 10.1165/ajrcmb.16.6.9191470.
4
beta(3)A-integrin downregulates the urokinase-type plasminogen activator receptor (u-PAR) through a PEA3/ets transcriptional silencing element in the u-PAR promoter.β(3)A整合素通过尿激酶型纤溶酶原激活物受体(u-PAR)启动子中的PEA3/ets转录沉默元件下调尿激酶型纤溶酶原激活物受体(u-PAR)。
Mol Cell Biol. 2001 Mar;21(6):2118-32. doi: 10.1128/MCB.21.6.2118-2132.2001.
5
Identification of an histone H3 acetylated/K4-methylated-bound intragenic enhancer regulatory for urokinase receptor expression.鉴定一种与组蛋白H3乙酰化/K4甲基化结合的、对尿激酶受体表达起调控作用的基因内增强子。
Oncogene. 2007 Mar 29;26(14):2058-70. doi: 10.1038/sj.onc.1210003. Epub 2006 Sep 25.
6
Ethanol-induced up-regulation of the urokinase receptor in cultured human endothelial cells.乙醇诱导培养的人内皮细胞中尿激酶受体上调。
Alcohol Clin Exp Res. 2001 Feb;25(2):163-70.
7
Binding of human single chain urokinase to Chinese Hamster Ovary cells and cloning of hamster u-PAR.人单链尿激酶与中国仓鼠卵巢细胞的结合及仓鼠尿激酶型纤溶酶原激活物受体的克隆
Thromb Haemost. 1998 Jul;80(1):148-54.
8
Generation and characterization of urokinase receptor-deficient mice.尿激酶受体缺陷小鼠的产生与特性研究
J Clin Invest. 1996 Feb 1;97(3):870-8. doi: 10.1172/JCI118489.
9
Identification of promoter regions involved in cell- and developmental stage-specific osteopontin expression in bone, kidney, placenta, and mammary gland: an analysis of transgenic mice.鉴定参与骨、肾、胎盘和乳腺中细胞及发育阶段特异性骨桥蛋白表达的启动子区域:转基因小鼠分析
J Bone Miner Res. 2004 Jan;19(1):78-88. doi: 10.1359/jbmr.2004.19.1.78.
10
Native atherosclerosis and vein graft arterialization: association with increased urokinase receptor expression in vitro and in vivo.原位动脉粥样硬化与静脉移植物动脉化:与体内外尿激酶受体表达增加相关。
Thromb Haemost. 1998 Jul;80(1):140-7.

引用本文的文献

1
Urokinase-type plasminogen activator receptor transcriptionally controlled adenoviruses eradicate pancreatic tumors and liver metastasis in mouse models.尿激酶型纤溶酶原激活物受体转录调控腺病毒可根除小鼠模型中的胰腺肿瘤和肝转移灶。
Neoplasia. 2009 Jun;11(6):518-28, 4 p following 528. doi: 10.1593/neo.81674.
2
Genetic evidence implicating multiple genes in the MET receptor tyrosine kinase pathway in autism spectrum disorder.遗传证据表明自闭症谱系障碍中MET受体酪氨酸激酶通路涉及多个基因。
Autism Res. 2008 Jun;1(3):159-68. doi: 10.1002/aur.27.

本文引用的文献

1
Urokinase receptor antibody can reduce tumor volume and detect the presence of occult tumor metastases in vivo.尿激酶受体抗体可减小肿瘤体积,并在体内检测隐匿性肿瘤转移的存在。
Cancer Res. 2002 Apr 15;62(8):2390-7.
2
The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R.尿激酶的纤维蛋白溶解受体激活G蛋白偶联趋化受体FPRL1/LXA4R。
Proc Natl Acad Sci U S A. 2002 Feb 5;99(3):1359-64. doi: 10.1073/pnas.022652999. Epub 2002 Jan 29.
3
Chromatin-specific regulation of LEF-1-beta-catenin transcription activation and inhibition in vitro.体外染色质特异性调控淋巴细胞增强因子1-β-连环蛋白转录激活与抑制
Genes Dev. 2001 Dec 15;15(24):3342-54. doi: 10.1101/gad.946501.
4
Chromatin remodeling, measured by a novel real-time polymerase chain reaction assay, across the proximal promoter region of the IL-2 gene.通过一种新型实时聚合酶链反应检测法测量白细胞介素-2基因近端启动子区域的染色质重塑。
J Immunol. 2001 Oct 15;167(8):4494-503. doi: 10.4049/jimmunol.167.8.4494.
5
Control elements between -9.5 and -3.0 kb in the human tissue-type plasminogen activator gene promoter direct spatial and inducible expression to the murine brain.人类组织型纤溶酶原激活剂基因启动子中-9.5至-3.0 kb之间的调控元件将空间和诱导型表达导向小鼠大脑。
Eur J Neurosci. 2001 Sep;14(5):799-808. doi: 10.1046/j.0953-816x.2001.01700.x.
6
Promoter function of different lengths of the murine luteinizing hormone receptor gene 5'-flanking region in transfected gonadal cells and in transgenic mice.不同长度的小鼠促黄体生成素受体基因5'-侧翼区在转染性腺细胞和转基因小鼠中的启动子功能
Endocrinology. 2001 Jun;142(6):2427-34. doi: 10.1210/endo.142.6.7994.
7
Gene expression patterns associated with the metastatic phenotype in rodent and human tumors.与啮齿动物和人类肿瘤转移表型相关的基因表达模式。
Cancer Res. 2001 Feb 15;61(4):1569-77.
8
beta(3)A-integrin downregulates the urokinase-type plasminogen activator receptor (u-PAR) through a PEA3/ets transcriptional silencing element in the u-PAR promoter.β(3)A整合素通过尿激酶型纤溶酶原激活物受体(u-PAR)启动子中的PEA3/ets转录沉默元件下调尿激酶型纤溶酶原激活物受体(u-PAR)。
Mol Cell Biol. 2001 Mar;21(6):2118-32. doi: 10.1128/MCB.21.6.2118-2132.2001.
9
The murine receptor for urokinase-type plasminogen activator is primarily expressed in tissues actively undergoing remodeling.
J Histochem Cytochem. 2001 Feb;49(2):237-46. doi: 10.1177/002215540104900211.
10
Matrix metalloproteinase 9 promoter activity is induced coincident with invasion during tumor progression.基质金属蛋白酶9启动子活性在肿瘤进展过程中与侵袭同时被诱导。
Am J Pathol. 2000 Dec;157(6):1777-83. doi: 10.1016/S0002-9440(10)64815-8.